InsidersTradesSigma
Explore the complete record of transactions filed by Gangolli Julian S, Director. Insider active across 1 companies, notably Revance Therapeutics, Inc.. Aggregated, 3 reports have been published. The latest transaction was disclosed on 4 May 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations
Julian S. Gangolli serves as a Board Member at Revance Therapeutics, Inc. He contributes to the governance of the company by bringing his expertise in strategy and business development. His role is crucial in guiding strategic decisions and ensuring the growth of the organization.